Risk of myeloid neoplasms after solid organ transplantation

Solid organ transplant recipients have elevated cancer risks, due in part to pharmacologic immunosuppression. However, little is known about risks for hematologic malignancies of myeloid origin. We linked the US Scientific Registry of Transplant Recipients with 15 population-based cancer registries...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Lindsay M., Gibson, Todd M., Clarke, Christina A., Lynch, Charles F., Anderson, Lesley A., Pfeiffer, Ruth, Landgren, Ola, Weisenburger, Dennis D., Engels, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197126/
https://www.ncbi.nlm.nih.gov/pubmed/24727673
http://dx.doi.org/10.1038/leu.2014.132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197126/
https://www.ncbi.nlm.nih.gov/pubmed/24727673
http://dx.doi.org/10.1038/leu.2014.132

Ejemplares similares